·
|
Third-quarter revenues increased 20.7% to $161.5 million compared to $133.8 million in the same period last year.
|
·
|
Operating income for the third quarter increased 10.2% to $13 million, compared to $11.8 million in the same period last year.
|
·
|
Net income for the third quarter increased 506% to $29.7 million, compared to $4.9 million in the same period last year. Net income for the third quarter of 2011 included income of $25.8 million recorded in connection with the acquisition by Sapiens International Corporation N.V. of two privately held companies (IDIT I.D.I. Technologies Ltd and FIS Software Ltd.), which was completed on August 21, 2011, following which Formula's holdings in Sapiens were reduced below 50%. As of September 30, 2011, Formula held 43.6% of Sapiens' outstanding share capital.
|
·
|
Revenues for the nine-month period ended September 30, 2011 increased 21.9% to $483.3 million, compared to $396.4 million in the same period last year.
|
·
|
Operating income for the nine-month period ended September 30, 2011 increased 12.9% to $38.5 million, compared to $34.1 million in the same period last year.
|
·
|
Net income for the nine-month period ended September 30, 2011 increased 187.4% to $38.8 million, compared to $13.5 million in the same period last year.
|
·
|
As of September 30, 2011, Formula’s consolidated cash and short term and long term investments in marketable securities totaled approximately $101.7 million, of which Formula’s standalone net cash and short term and long term investments totaled $5.8 million (with no debt).
|
·
|
As of September 30, 2011, total equity was $351.2 million, representing 57% of the total balance sheet.
|
Three months ended
|
Nine months ended
|
|||||||||||||||
September 30,
|
September 30,
|
|||||||||||||||
2011
|
2010
|
2011
|
2010
|
|||||||||||||
Unaudited
|
Unaudited
|
|||||||||||||||
Revenues
|
161,497 | 133,791 | 483,288 | 396,357 | ||||||||||||
Cost of revenues
|
123,409 | 100,282 | 369,147 | 297,330 | ||||||||||||
Gross profit
|
38,088 | 33,509 | 114,141 | 99,027 | ||||||||||||
Research and development costs, net
|
1,440 | 1,399 | 4,660 | 3,993 | ||||||||||||
Selling, general and administrative expenses
|
23,675 | 20,320 | 70,940 | 60,944 | ||||||||||||
Operating income
|
12,973 | 11,790 | 38,541 | 34,090 | ||||||||||||
Financial expenses, net
|
(1,813 | ) | (1,033 | ) | (4,959 | ) | (2,754 | ) | ||||||||
11,160 | 10,757 | 33,582 | 31,336 | |||||||||||||
Other income, net
|
54 | 301 | 231 | 148 | ||||||||||||
Income before taxes on income
|
11,214 | 11,058 | 33,813 | 31,484 | ||||||||||||
Taxes on income
|
1,917 | 1,718 | 5,778 | 5,089 | ||||||||||||
9,297 | 9,340 | 28,035 | 26,395 | |||||||||||||
Gain derived from deconsolidation of subsidiary and
|
||||||||||||||||
equity in gains (losses) of affiliated companies, net
|
25,583 | (271 | ) | 25,446 | (649 | ) | ||||||||||
Net income
|
34,880 | 9,069 | 53,481 | 25,746 | ||||||||||||
Net income attributable to non-controlling interests
|
5,223 | 4,193 | 14,635 | 12,237 | ||||||||||||
Net income attributable to Formula's shareholders
|
29,657 | 4,876 | 38,846 | 13,509 | ||||||||||||
Earnings per share:
|
||||||||||||||||
Basic
|
2.19 | 0.36 | 2.88 | 1.01 | ||||||||||||
Diluted
|
2.16 | 0.36 | 2.81 | 1.00 | ||||||||||||
Weighted average number of shares outstanding:
|
||||||||||||||||
Basic
|
13,530 | 13,398 | 13,497 | 13,365 | ||||||||||||
Diluted
|
13,674 | 13,530 | 13,666 | 13,522 |
September 30,
|
December 31,
|
|||||||
2011
|
2010
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
64,827 | 110,508 | ||||||
Marketable securities
|
24,315 | 38,170 | ||||||
Short-term deposits
|
9,800 | 24 | ||||||
Trade receivables
|
140,191 | 154,366 | ||||||
Other accounts receivable
|
29,784 | 23,140 | ||||||
Inventories
|
3,036 | 5,601 | ||||||
Total current assets
|
271,953 | 331,809 | ||||||
LONG-TERM INVESTMENTS:
|
||||||||
Marketable securities
|
2,805 | 2,828 | ||||||
Deferred Taxes
|
13,509 | 13,135 | ||||||
Investments in affiliated company
|
73,156 | 3,209 | ||||||
Prepaid expenses and other assets
|
4,409 | 5,493 | ||||||
Total long-Term Investments
|
93,879 | 24,665 | ||||||
SEVERANCE PAY FUND
|
49,438 | 55,286 | ||||||
PROPERTY, PLANTS AND EQUIPMENT, NET
|
19,031 | 12,411 | ||||||
NET INTANGIBLE ASSETS AND GOODWILL
|
183,861 | 199,596 | ||||||
TOTAL ASSETS
|
618,162 | 623,767 | ||||||
LIABILITIES AND EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Liabilities to banks
|
5,692 | 6,684 | ||||||
Trade payables
|
38,596 | 53,177 | ||||||
Deferred revenues
|
20,720 | 26,845 | ||||||
Employees and payroll accrual
|
36,838 | 40,704 | ||||||
Other accounts payable
|
24,140 | 30,693 | ||||||
Dividend payable to non controling interests
|
511 | - | ||||||
Liability in respect of business combinations
|
4,231 | 3,963 | ||||||
Debentures
|
16,250 | 15,927 | ||||||
Total current liabilities
|
146,978 | 177,993 | ||||||
LONG-TERM LIABILITIES:
|
||||||||
Debentures
|
31,309 | 31,854 | ||||||
Deferred taxes
|
3,184 | 2,654 | ||||||
Customer advances
|
2,588 | 3,520 | ||||||
Liabilities to banks and others
|
7,406 | 3,154 | ||||||
Liability in respect of business combinations
|
12,157 | 4,758 | ||||||
Accrued severance pay
|
63,294 | 65,450 | ||||||
Total long-term liabilities
|
119,938 | 111,390 | ||||||
EQUITY
|
||||||||
Formula shareholders' equity
|
218,541 | 197,615 | ||||||
Non-controlling interests
|
132,705 | 136,769 | ||||||
Total equity
|
351,246 | 334,384 | ||||||
TOTAL LIABILITIES AND EQUITY
|
618,162 | 623,767 |